Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Communication Disorders × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3 Lymphoid 1 CNS 1

Conditions

Brain Neoplasms 2099 Glioblastoma 1813 Glioma 1268 Central Nervous System Neoplasms 629 Astrocytoma 602 Neuroblastoma 585 Gliosarcoma 443 Oligodendroglioma 371 Neoplasms 369 Breast Neoplasms 297 Medulloblastoma 269 Carcinoma, Non-Small-Cell Lung 233 Meningioma 210 Recurrence 200 Sarcoma 194 Melanoma 185 Ependymoma 184 Neoplasm Metastasis 181 Lung Neoplasms 172 Neurofibromatosis 1 154 Lymphoma 144 Meningeal Carcinomatosis 126 Osteosarcoma 122 Ovarian Neoplasms 116 Wilms Tumor 115 Precursor Cell Lymphoblastic Leukemia-Lymphoma 110 Lymphoma, Non-Hodgkin 108 Diffuse Intrinsic Pontine Glioma 104 Head and Neck Neoplasms 101 Rhabdomyosarcoma 98

Interventions

Speech Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05189366 2025-10-07

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡